Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00837746 · ClinicalTrials.gov registry record
Analysis of Iliac Crest Biopsies From Patients Receiving Risedronate
A clinical trial, sponsored by Warner Chilcott.
- Completed
- Registry status
- 29
- Enrollment target
NCT00837746 is a clinical trial that has completed, run by Warner Chilcott. The registered enrollment target is 29 participants.
The verdict
NCT00837746 has completed, sponsored by Warner Chilcott.
- COMPLETED
- Registry status
- 29 participants
- Enrollment target
Study Summary
This study analysed and reported on the study data from three similar, risedronate studies, 1996052, 2003073, and 2003096. The objective of the study was to determine the differences in the iliac crest bone histomorphometry and bone quality in postmenopausal women who had received long term therapy with risedronate.
Interventions
- DRUG risedronate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 29 participants |
| Start Date | 2003-04 |
| Est. Completion | 2006-10 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00837746
The ClinicalTrials.gov registry entry for NCT00837746 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 29 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Warner Chilcott, which has 53 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which risedronate is the first listed.
NCT00837746 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00837746 about?
NCT00837746 is a clinical study titled "Analysis of Iliac Crest Biopsies From Patients Receiving Risedronate". This study analysed and reported on the study data from three similar, risedronate studies, 1996052, 2003073, and 2003096. The objective of the study was to determine the differences in the iliac crest bone histomorphometry and bone quality in postmenopausal women who had received long term therapy ...
What is the current status of trial NCT00837746?
This trial is currently completed. The enrollment target is 29 participants. The study started on 2003-04. Estimated completion is 2006-10.
What interventions are being tested in trial NCT00837746?
The interventions under investigation include: risedronate (DRUG).
Who is sponsoring clinical trial NCT00837746?
This trial is sponsored by Warner Chilcott, which has 53 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.